ATLANTA — Osmotica Pharmaceutical Corp. will open a U.S. R&D and manufacturing operation in Marietta.
The company plans to create 156 jobs over five years, many of which will be high-wage positions, state officials say. The new facility also represents a $20 million investment over the next five years.
The company currently utilizes five contract manufacturers around the United States to produce its products.
“Georgia is becoming a global player in the bioscience industry, and our aggressive efforts to attract companies such as Osmotica is a great marker of our ability to compete in this area,” Gov. Nathan Deal said in a news release. “We have the infrastructure in place that will encourage success as Osmotica opens its first U.S. facility right here in our state. From our premier research institutions, the strength of our progressive business environment and robust pool of talent, Georgia is well equipped as a strategic home for the bioscience industry.”